Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Oct;63(10):1183–1185. doi: 10.1136/ard.2004.023937

Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?

B Hellmich 1, I Kausch 1, C Doehn 1, D Jocham 1, K Holl-Ulrich 1, W Gross 1
PMCID: PMC1754742  PMID: 15361369

Full Text

The Full Text of this article is available as a PDF (54.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansell I. D., Castro J. E. Carcinoma of the bladder complicating cyclophosphamide therapy. Br J Urol. 1975 Aug;47(4):413–418. doi: 10.1111/j.1464-410x.1975.tb03998.x. [DOI] [PubMed] [Google Scholar]
  2. Brockmann Holger, Schwarting Andreas, Kriegsmann Jörg, Petrow Peter, Gaumann Andreas, Müller Klaus-Michael, Galle Peter Robert, Mayet Werner. Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis. Arthritis Res. 2002 Mar 27;4(3):220–225. doi: 10.1186/ar410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cox P. J. Cyclophosphamide cystitis--identification of acrolein as the causative agent. Biochem Pharmacol. 1979 Jul 1;28(13):2045–2049. doi: 10.1016/0006-2952(79)90222-3. [DOI] [PubMed] [Google Scholar]
  4. Fairchild W. V., Spence C. R., Solomon H. D., Gangai M. P. The incidence of bladder cancer after cyclophosphamide therapy. J Urol. 1979 Aug;122(2):163–164. doi: 10.1016/s0022-5347(17)56306-5. [DOI] [PubMed] [Google Scholar]
  5. Hattar Katja, Grandel Ulrich, Bickenbach Annette, Schwarting Andreas, Mayet Werner-Johannes, Bux Jürgen, Jessen Sönke, Fischer Claus, Seeger Werner, Grimminger Friedrich. Interaction of antibodies to proteinase 3 (classic anti-neutrophil cytoplasmic antibody) with human renal tubular epithelial cells: impact on signaling events and inflammatory mediator generation. J Immunol. 2002 Mar 15;168(6):3057–3064. doi: 10.4049/jimmunol.168.6.3057. [DOI] [PubMed] [Google Scholar]
  6. Hoffman G. S., Kerr G. S., Leavitt R. Y., Hallahan C. W., Lebovics R. S., Travis W. D., Rottem M., Fauci A. S. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992 Mar 15;116(6):488–498. doi: 10.7326/0003-4819-116-6-488. [DOI] [PubMed] [Google Scholar]
  7. Horman S., Fokan D., Galand P. MCF-7 mammary tumour cells express the myeloid cell differentiation controlling factor, serine protease 3/myeloblastin. Cell Prolif. 2000 Oct;33(5):331–340. doi: 10.1046/j.1365-2184.2000.00188.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hows J. M., Mehta A., Ward L., Woods K., Perez R., Gordon M. Y., Gordon-Smith E. C. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Br J Cancer. 1984 Dec;50(6):753–756. doi: 10.1038/bjc.1984.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. King W. J., Adu D., Daha M. R., Brooks C. J., Radford D. J., Pall A. A., Savage C. O. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol. 1995 Oct;102(1):98–105. doi: 10.1111/j.1365-2249.1995.tb06642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Knight A., Askling J., Granath F., Sparen P., Ekbom A. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis. 2004 May 6;63(10):1307–1311. doi: 10.1136/ard.2003.019125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Knight Ann, Askling Johan, Ekbom Anders. Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis. Int J Cancer. 2002 Jul 1;100(1):82–85. doi: 10.1002/ijc.10444. [DOI] [PubMed] [Google Scholar]
  12. Kurzrock R., Cohen P. R., Markowitz A. Clinical manifestations of vasculitis in patients with solid tumors. A case report and review of the literature. Arch Intern Med. 1994 Feb 14;154(3):334–340. [PubMed] [Google Scholar]
  13. Lüdemann J., Utecht B., Gross W. L. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med. 1990 Jan 1;171(1):357–362. doi: 10.1084/jem.171.1.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mukhopadhyay Sanjay, Shrimpton Anthony E., Jones Lee A., Nsouli Imad S., Abraham Naif Z., Jr Carcinosarcoma of the urinary bladder following cyclophosphamide therapy: evidence for monoclonal origin and chromosome 9p allelic loss. Arch Pathol Lab Med. 2004 Jan;128(1):e8–11. doi: 10.5858/2004-128-e8-COTUBF. [DOI] [PubMed] [Google Scholar]
  15. Reinhold-Keller E., Beuge N., Latza U., de Groot K., Rudert H., Nölle B., Heller M., Gross W. L. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000 May;43(5):1021–1032. doi: 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  16. Reinhold-Keller E., Mohr J., Christophers E., Nordmann K., Gross W. L. Mesna side effects which imitate vasculitis. Clin Investig. 1992 Aug;70(8):698–704. doi: 10.1007/BF00180290. [DOI] [PubMed] [Google Scholar]
  17. Relle Manfred, Mayet Werner J., Strand Dennis, Brenner Walburgis, Galle Peter R., Schwarting Andreas. Proteinase 3/myeloblastin as a growth factor in human kidney cells. J Nephrol. 2003 Nov-Dec;16(6):831–840. [PubMed] [Google Scholar]
  18. Schwarting A., Hagen D., Odenthal M., Brockmann H., Dienes H. P., Wandel E., Rumpelt H. J., Zum Büschenfelde K. H., Galle P. R., Mayet W. Proteinase-3 mRNA expressed by glomerular epithelial cells correlates with crescent formation in Wegener's granulomatosis. Kidney Int. 2000 Jun;57(6):2412–2422. doi: 10.1046/j.1523-1755.2000.00100.x. [DOI] [PubMed] [Google Scholar]
  19. Sneller M. C. Cystitis, bladder cancer, and myelodysplasia in patients with Wegener's granulomatosis: comment on the article by Reinhold-Keller et al. Arthritis Rheum. 2000 Dec;43(12):2853–2855. doi: 10.1002/1529-0131(200012)43:12<2853::AID-ANR30>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  20. Stillwell T. J., Benson R. C., Jr Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer. 1988 Feb 1;61(3):451–457. doi: 10.1002/1097-0142(19880201)61:3<451::aid-cncr2820610308>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  21. Stillwell T. J., Benson R. C., Jr, DeRemee R. A., McDonald T. J., Weiland L. H. Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum. 1988 Apr;31(4):465–470. doi: 10.1002/art.1780310402. [DOI] [PubMed] [Google Scholar]
  22. Talar-Williams C., Hijazi Y. M., Walther M. M., Linehan W. M., Hallahan C. W., Lubensky I., Kerr G. S., Hoffman G. S., Fauci A. S., Sneller M. C. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med. 1996 Mar 1;124(5):477–484. doi: 10.7326/0003-4819-124-5-199603010-00003. [DOI] [PubMed] [Google Scholar]
  23. Tatsis E., Reinhold-Keller E., Steindorf K., Feller A. C., Gross W. L. Wegener's granulomatosis associated with renal cell carcinoma. Arthritis Rheum. 1999 Apr;42(4):751–756. doi: 10.1002/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  24. Witko-Sarsat Véronique, Canteloup Sandrine, Durant Stéphanie, Desdouets Chantal, Chabernaud Romain, Lemarchand Patricia, Descamps-Latscha Béatrice. Cleavage of p21waf1 by proteinase-3, a myeloid-specific serine protease, potentiates cell proliferation. J Biol Chem. 2002 Sep 26;277(49):47338–47347. doi: 10.1074/jbc.M202789200. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES